The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Images in Clinical Medicine
PreviousPrevious
Volume 355:e20 November 2, 2006 Number 18
NextNext

Necrobiosis Lipoidica Diabeticorum

 

This Article
- PDF

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-PubMed Citation
Figure 1
View larger version (77K):
[in this window]
[in a new window]
Get Slide
 
A 52-year-old man with diabetes reported a 3-month history of a pretibial rash during a routine visit. He had a 15-year history of type 2 diabetes mellitus treated with insulin and a 3-year history of congestive heart failure. The lesions had begun to ulcerate and bleed but were not pruritic or painful. Physical examination showed yellow–brown plaques with ulcerations and telangiectases in the thinned epidermis. A diagnosis of necrobiosis lipoidica diabeticorum — an inflammatory skin disorder characterized by irregularly shaped, callous lesions with reddish-brown pigmentation and central atrophy — was made on the basis of visual inspection. In necrobiosis lipoidica diabeticorum, the shins, ankles, and feet are typically affected, but 15% of patients may have lesions elsewhere. The disorder is more common among women than men and is more common among persons with diabetes than those without. Microscopical studies have shown that it is a disorder of collagen degeneration characterized by a granulomatous response, thickening of the walls of blood vessels, and fat deposition. The exact cause is unknown. Necrobiosis lipoidica diabeticorum may be an antibody-mediated vasculitis with secondary collagen degeneration or the microangiopathy of diabetes (but it is not correlated with the extent of glucose control). Treatment may include occlusive dressings, topical and subcutaneous corticosteroids, and antiplatelet therapy. Flare-ups are frequent. No treatment is completely effective. The patient was referred to a dermatologist for continuing care, but he died suddenly at home.

 

Nicole Wake, B.A.
James C. Fang, M.D.
Brigham and Women's Hospital
Boston, MA 02115
nwake{at}partners.org




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.